SHOCKING “DATA GAPS” IN NEW J&J VACCINE - The HighWire

Back to parent episode

The Johnson & Johnson vaccine will mark the third COVID-19 vaccine approved by the FDA for emergency use, and the mainstream media is already praising it. Jefferey Jaxen breaks down the fine print on the experimental drug’s efficacy, as well as the unknown risks and data gaps published by the FDA themselves.

POSTED: March 9, 2021

Only Episodes

to